Market News AIOpen the app

LEGN stock news · Legend Biotech

Stories about Legend Biotech (LEGN) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for LEGN

Follow Legend Biotech (LEGN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LEGN
Free on the App Store and Google Play, or on the web.
  1. Nov 10, 2026, 9:21 AM ET · Results

    Legend Biotech shared its earnings call, showing a 36% jump in CARVYKTI sales to $710 million.

    Good for LEGN

    Legend Biotech said CARVYKTI sales rose 36% to $710 million, with study progress and a 2026 profit goal also reported. The update reads favorably for Legend.